BrainGate Neural Interface for Aphasia
(BG-Aphasia-02 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
In this study, the investigators aim to continue the development of a brain-computer interface (BCI) to help restore speech for stroke survivors with agrammatic aphasia, a language disorder that affects the ability to speak.
Are You a Good Fit for This Trial?
This trial is for adults who have lost the ability to speak clearly due to a stroke that caused agrammatic aphasia. Participants should be generally healthy enough for surgery and able to take part in study activities.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- BrainGate Neural Interface System
Trial Overview
The study is testing the BrainGate Neural Interface System, a brain-computer interface designed to help people with speech loss after stroke communicate again. The device records brain signals and translates them into speech or text.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Device: BrainGate Neural Interface System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Leigh R. Hochberg, MD, PhD.
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.